Cargando…

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous carcinoma (ESCC) is one of the most common cancers in developing countries. However, currently there are no specific biomarkers for ESCC. This study evaluated the expression of proliferating cell nuclear antigen (PCNA), tumor suppressor protein p53, epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jiebing, Li, Xinglin, Li, Dan, Liu, Ye, Cao, Wanwei, Chen, Xiaoyun, Li, Zhijun, Wang, Xiaojing, Cao, Qingdong, Peng, Tukang, Jin, Hongjun, Shan, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339853/ https://www.ncbi.nlm.nih.gov/pubmed/34422998 http://dx.doi.org/10.21037/atm-21-2950

Ejemplares similares

Immunohistochemistry (IHC) staining of in-vitro cancer cell-generated tumoroids
por: Amereh, Meitham, et al.
Publicado: (2023)

IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
por: Varghese, Frency, et al.
Publicado: (2014)

Loss-of-function Mutations K11E or E271K Lead to Novel Tumor Suppression, Implicate Nucleolar Helicase DDX24 Oncogenicity
por: Li, Xinglin, et al.
Publicado: (2022)

Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma
por: Wang, Yu, et al.
Publicado: (2022)

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
por: Taube, Janis M, et al.
Publicado: (2020)

Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
por: Sui, Weiguo, et al.
Publicado: (2009)

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer
por: Phillips, Therese, et al.
Publicado: (2015)

Correction: The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Publicado: (2020)

On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) data
por: Seal, Souvik, et al.
Publicado: (2022)

Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative
por: Ma, Di, et al.
Publicado: (2016)

Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
por: Goud, Kalal Iravathy, et al.
Publicado: (2012)

Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry
por: Richter, Annika, et al.
Publicado: (2021)

Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
por: Chae, Young Kwang, et al.
Publicado: (2017)

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma
por: Shu, Wenbin, et al.
Publicado: (2022)

Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer
por: Yu, Yue, et al.
Publicado: (2019)

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx
por: Kalpakoff, Megan, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications
por: Li, Shu-Ping, et al.
Publicado: (2016)

Elevated Nectin-2 expression is involved in esophageal squamous cell carcinoma by promoting cell migration and invasion
por: Li, Ming, et al.
Publicado: (2018)

Metformin and oxyphotodynamic therapy as a novel treatment approach for triple-negative breast cancer
por: Pei, Xiaofeng, et al.
Publicado: (2020)

Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma
por: Minakata, Nobuhisa, et al.
Publicado: (2023)

Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934
por: Sompuram, Seshi R., et al.
Publicado: (2022)

Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer
por: Wang, Jiayang, et al.
Publicado: (2020)

Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma
por: Cheng, Rui, et al.
Publicado: (2018)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

miR-92a-3p promotes the proliferation, migration and invasion of esophageal squamous cell cancer by regulating PTEN
por: Li, Xin, et al.
Publicado: (2019)

Quantitative Analysis of Immunohistochemistry in Melanoma Tumors
por: Lilyquist, Jenna, et al.
Publicado: (2017)

Exosomal Sonic Hedgehog derived from cancer‐associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma
por: Zhao, Guiping, et al.
Publicado: (2020)

Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification
por: Varga, Zsuzsanna, et al.
Publicado: (2014)

Automated classification of protein expression levels in immunohistochemistry images to improve the detection of cancer biomarkers
por: Xue, Zhen-Zhen, et al.
Publicado: (2022)

P53 IHC Result as a Prognostic Tool in MDS
por: Rezvani, Alireza, et al.
Publicado: (2023)

FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma
por: Zhao, Yu, et al.
Publicado: (2019)

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women
por: Joosten, Stacey E. P., et al.
Publicado: (2021)

Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining
por: Xu, Zekun, et al.
Publicado: (2023)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts
por: He, Helen, et al.
Publicado: (2016)

Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
por: Zito Marino, Federica, et al.
Publicado: (2020)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
por: Zhu, Yanping, et al.
Publicado: (2019)

Automated sequential chromogenic IHC double staining with two HRP substrates
por: Petersen, Kenneth Heesche, et al.
Publicado: (2018)

IHC Color Histograms for Unsupervised Ki67 Proliferation Index Calculation
por: Geread, Rokshana S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fp03jatcmeu1olenhvrsk3uksq